INTRODUCTION: Delay in the diagnosis of cancers of the larynx affects the prognosis and often requires very mutilating surgery. AIM: To report the oncologic and functional outcomes of surgery for laryngeal cancers to Hôpital Principal de Dakar in Senegal. MATERIALS AND METHODS: This was a single-center retrospective study carried out from January 2009 to December 2014 in the ENT and head and neck surgery department including adult patients treated for curative surgery. RESULTS: Fifty patients were treated for laryngeal cancer. Thirty-seven of them underwent a laryngectomy. Lesions classified as cT2 represented 14%, and 16% were classified as cT1. Squamous cell carcinomas represented more than 97% of cases (36/37). Radiotherapy had completed the surgery in only 11 cases with an average delay of 2.75 months. Functionally, swallowing disorders were found in two patients with two cases of pharyngo-esophageal stenosis. On the carcinologic level, six patients presented a progression while four had tumor or lymph node recurrence. One patient showed lung metastasis. Overall survival at 7 years was 33%. CONCLUSION: The functional damage in laryngeal cancer surgery is significant and on the carcinologic level the results, although satisfactory, can be improved with a better availability of adjuvant treatments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.